Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients.
Pediatric demyelinating diseases.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
CLIPPERS-like MRI findings in a patient with multiple sclerosis.
Immunopathological characteristics of patients with bullous pemphigoid and neurological disease.
Linked in and up to speed.
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
[New therapeutic options in multiple sclerosis].
Neuroplasticity and motor rehabilitation in multiple sclerosis.
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Financial Incentives, Workplace Wellness Program Participation, and Utilization of Health Care Services and Spending.
Immunity and inflammation in neurodegenerative diseases.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Pathological differences between white and grey matter multiple sclerosis lesions.
Interventions for children coping with parental multiple sclerosis: A systematic review.
Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Genomic medicine and risk prediction across the disease spectrum.
[Symptoms and clinical manifestations in neuromyelitis optica].
[Structural and functional changes of the hippocampus in patients with multiple sclerosis and their relationship with memory processes].
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

Pages